Stoke Therapeutics (STOK) Stock Price
$9.36 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
7 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Stoke Therapeutics, AI stock picks, stock alerts and much more.
STOK AI Stock Analysis
AI stock analysis for STOK is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Stoke Therapeutics (STOK) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Stoke Therapeutics (STOK) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Stoke Therapeutics (STOK), currently trading at $9.36, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About STOK
-
Stoke Therapeutics, Inc.
-
Symbol
STOK
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
511M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.37 2.7% |
6 |
 |
Inovio Pharmaceuticals INO |
$1.8 1.1% |
1 |
 |
Moderna MRNA |
$24.25 0.5% |
3 |
 |
Anavex Life Sciences AVXL |
$8.25 3.6% |
5 |
 |
BridgeBio Pharma BBIO |
$34.17 2% |
6 |
News
STOK Alternative Data
Web Traffic
Stoke Therapeutics receives an estimated 8174 monthly visitors to stoketherapeutics.com, which is down by -16.6% over the last month.
-
Web Traffic
8174
-
Change from Previous Month
16.6%
-
3 Month Change
9.6%
-
YoY Change
9.6%
LinkedIn Followers
14,705 are following Stoke Therapeutics on LinkedIn, up by 1.2% over the last month.
-
LinkedIn Followers
14705
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
8%
Job Postings
Stoke Therapeutics has an estimated 3 open job postings, which is down -25% over the last month.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
25%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Employees
According to LinkedIn, Stoke Therapeutics has 148 employees, up by 4.2% over the last month.
-
LinkedIn Employees
148
-
Daily Change
0%
-
1 Month Change
4.2%
-
3 Month Change
7.2%
-
YoY Change
7.2%
Reddit Mentions
Stoke Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Stoke Therapeutics has 1,532 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
1532
-
Daily Change
0.1%
-
1 Month Change
0.3%
-
3 Month Change
0.2%
-
YoY Change
0.2%
News Mentions
Stoke Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Stoke Therapeutics is 85 out of 100 (very bullish).
-
Business Outlook
85
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
STOK Financials
STOK Key Metrics
-
Total Revenue
$22.6M
-
Net Income
-$10.5M
-
Earnings per Share
-$0.19
-
Free cash flow
-$23.2M
-
EBITDA
-$13.1M
-
EBITDA Ratio
-0.580481
-
Total Assets
$271.6M
STOK 2-year Revenue & Income
STOK 2-year Free Cash Flow
STOK Technicals
STOK SMA
STOK RSI
FAQ
What's the current price of Stoke Therapeutics (STOK) Stock?
The price of an Stoke Therapeutics (STOK) share is $9.36.
What's the market cap of Stoke Therapeutics?
The current market cap of Stoke Therapeutics is 511M.
Should I buy or sell STOK?
Stoke Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Stoke Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Stoke Therapeutics a good investment?
The current analysis of Stoke Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Stoke Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Stoke Therapeutics (STOK) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Stoke Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Stoke Therapeutics (STOK) that investors often compare it to?
Stoke Therapeutics (STOK) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Stoke Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Stoke Therapeutics' stock price to be around $9.32 in 2026. Starting from the current price of $9.36, this represents a 0.5% change in price, indicating a neutral outlook for the stock.
How to buy Stoke Therapeutics (STOK) Stock?
Stoke Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Stoke Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.